We follow industry news and trends so you can stay ahead of the game. Subscribe to receive emails regarding policies and findings that impact you and your business.

Already a subscriber and want to update your preferences? Click here.

BACK TO NEWS

MEDIA MENTIONS

NOV 23 2016

William A. Garvin Quoted in Bloomberg Law Article on the FDA’s Decision to Halt All Lab Tests

William A. Garvin, shareholder in Buchanan’s FDA & Pharmaceuticals practice, was quoted in a Bloomberg Law article titled, “FDA Delays Lab Test Changes Until Trump Takes Office.”

“Given the fact that people are uncertain about what the new administration is going to do with regards to certain FDA regulatory positions and priorities, the FDA is trying its best to hold off on taking positions that would need to get revised once Trump is in office,” Garvin said.